Research Article
Systematic Review and Meta-Analysis of Randomized Controlled Trials of Fuke Qianjin Tablet
Table 3
Risk of bias evaluation of included literature.
| | Study ID | Random sequence generation (selection bias) | Allocation concealment (selection bias) | Blinding of participants and personnel (performance bias) | Blinding of outcome assessment (detection bias) | Incomplete outcome data (attrition bias) | Selective reporting (reporting bias) | Other bias |
| | Acute pelvic inflammatory | | CCJ (2018) [27] | U | U | U | U | L | L | U | | YML (2013) [28] | U | U | U | U | L | L | U | | ZJ (2017) [29] | L | U | U | U | L | L | U | | DY (2014) [30] | U | U | U | U | L | L | U | | SL (2015) [31] | U | U | U | U | L | L | U | | TSQ (2019) [32] | U | U | U | U | L | L | U | | XQX (2014) [33] | U | U | U | U | L | H | U | | YFY (2013) [34] | U | U | U | U | L | L | U | | RS (2012) [35] | U | U | U | U | L | L | U | | SFM (2015) [36] | U | U | U | U | L | L | U | | ZY (2013) [37] | U | U | U | U | L | L | U | | FXH (2018) [38] | L | U | U | U | L | L | U | | SYQ (2015) [39] | U | U | U | U | L | L | U | | ZHY (2012) [40] | U | U | U | U | L | L | U | | ZYZ (2012) [41] | U | U | U | U | L | L | U | | YCQ (2017) [42] | U | U | U | U | L | L | U | | LWR (2013) [43] | U | U | U | U | L | L | U | | WGJ (2011) [44] | U | U | U | U | L | L | U | | HRM (2013) [45] | U | U | U | U | L | L | U | | GSY (2012) [46] | U | U | U | U | L | L | U | | ZYH (2016) [47] | U | U | U | U | L | L | U | | ZNN (2012) [48] | U | U | U | U | L | L | U | | LJ (2014) [49] | U | U | U | U | L | L | U |
| | Chronic pelvic inflammatory | | LJX2 (2014) [50] | U | U | U | U | L | L | U | | XZJ (2007) [51] | H | U | U | U | L | L | U | | CXC (2019) [52] | U | U | U | U | L | L | U | | DJL (2014) [53] | U | U | U | U | L | L | U | | PGZ (2016) [54] | H | U | U | U | L | L | U | | SXL (2015) [55] | L | U | U | U | L | L | U | | WQF (2013) [56] | U | U | U | U | L | L | U | | ZXJ (2015) [57] | L | U | U | U | L | L | U | | ZMY (2017) [58] | U | U | U | U | L | L | U | | LJX1 (2014) [50] | U | U | U | U | L | L | U | | LXX (2019) [59] | L | U | U | U | L | L | U | | LH (2019) [60] | U | U | U | U | L | L | U | | PJQ (2019) [61] | U | U | U | U | L | L | U | | SWA (2014) [62] | U | U | U | U | L | L | U | | SQB2 (2012) [63] | U | U | U | U | L | L | U | | ZY (2014) [64] | U | U | U | U | L | L | U | | SQB1 (2012) [63] | U | U | U | U | L | L | U | | SPF (2015) [65] | U | U | U | U | L | L | U | | CF (2018) [66] | U | U | U | U | L | L | U | | DLL (2017) [67] | U | U | U | U | L | L | U | | FJY (2010) [68] | U | U | U | U | L | L | U | | FP (2013) [69] | U | U | U | U | L | L | U | | KY (2018) [70] | U | U | U | U | L | L | U | | LMY (2016) [71] | U | U | U | U | L | L | U | | LYK (2016) [72] | U | U | U | U | L | L | U | | LongH (2011) [73] | U | U | U | U | L | L | U | | RDQ (2019) [74] | U | U | U | U | L | L | U | | ShaoXL (2012) [75] | U | U | U | U | L | L | U | | TXG (2015) [76] | U | U | U | U | L | L | U | | WJP (2013) [77] | U | U | U | U | H | L | U | | YM (2017) [78] | U | U | U | U | L | L | U | | YQ (2014) [79] | U | U | U | U | L | L | U | | ZYL (2017) [80] | L | U | U | U | L | L | U | | DLH (2019) [81] | H | U | U | U | L | L | U | | HJY (2019) [82] | L | U | U | U | L | L | U | | LJ (2019) [83] | U | L | L | U | L | L | U | | SJL (2016) [84] | U | U | U | U | L | L | U | | WJ (2018) [85] | L | U | U | U | L | L | U | | ZL (2015) [86] | U | U | U | U | L | L | U | | ZT (2018) [87] | U | U | U | U | L | L | U | | ZhaoJ (2017) [88] | U | U | U | U | L | L | U | | ZengJ (2016) [89] | U | U | U | U | L | L | U | | CXF (2018) [90] | U | U | U | U | L | L | U | | DCM (2016) [91] | U | U | U | U | L | L | U | | DQY (2015) [92] | U | U | U | U | L | L | U | | HSX (2019) [93] | H | U | U | U | L | L | U | | HHJ (2019) [94] | L | U | U | U | L | L | U | | HHM (2019) [95] | L | U | U | U | L | L | U | | HYL (2015) [96] | L | U | U | U | L | L | U | | LML (2019) [97] | U | U | U | U | L | L | U | | LHR (2013) [98] | U | U | U | U | L | L | U | | LXL (2018) [99] | L | U | U | U | L | L | U | | LSY (2018) [100] | L | U | U | U | L | L | U | | LYZ (2012) [101] | H | U | U | U | L | L | U | | MYQ (2019) [102] | U | U | U | U | L | L | U | | RC (2016) [103] | U | U | U | U | L | L | U | | RL (2017) [104] | L | U | U | U | L | L | U | | SNY·HSY (2016) [105] | U | U | U | U | L | L | U | | SQJ (2012) [106] | U | U | U | U | L | L | U | | YLH (2012) [107] | U | U | U | U | L | L | U | | WDD (2017) [108] | L | U | U | U | L | L | U | | WHL (2011) [109] | U | U | U | U | L | L | U | | WLY (2019) [110] | U | U | U | U | L | L | U | | WSY (2011) [111] | U | U | U | U | L | L | U | | WY (2018) [112] | L | U | U | U | L | L | U | | WDM (2019) [113] | U | U | U | U | L | L | U | | XW (2015) [114] | U | U | U | U | L | L | U | | XRQ (2018) [115] | U | U | U | U | L | L | U | | YDM (2015) [116] | U | U | U | U | L | L | U | | YXH (2016) [117] | L | U | U | U | L | L | U | | ZhangJ (2017) [118] | U | U | U | U | L | L | U |
| | Endometritis | | SFF (2017) [119] | U | U | U | U | L | L | U | | SCP (2019) [120] | U | U | U | U | L | L | U | | DYY (2019) [121] | U | U | U | U | L | L | U | | LY (2019) [122] | U | U | U | U | L | L | U | | HHF (2017) [123] | L | U | U | U | L | L | U | | WJF (2019) [124] | U | U | U | U | L | L | U | | MTX (2016) [125] | U | U | U | U | L | L | U | | SXW (2018) [126] | L | U | U | U | L | L | U | | ZHH (2018) [127] | L | U | U | U | L | L | U | | ZL (2019) [128] | L | U | U | U | L | L | U | | DCL (2017) [129] | U | U | U | U | L | L | U | | DFY (2017) [130] | L | U | U | U | L | L | U | | GY(2015) [131] | L | U | U | U | L | L | U | | LWP (2019) [132] | L | U | U | U | L | L | U | | MYJ (2018) [133] | L | U | U | U | L | L | U | | DFL (2017) [134] | U | U | U | U | L | L | U | | HXY (2018) [135] | U | U | U | U | L | L | U | | ZQ (2019) [136] | U | U | U | U | L | L | U | | LXZ (2017) [137] | U | U | U | U | L | L | U | | CXH (2017) [138] | L | U | U | U | L | L | U | | FCF (2016) [139] | U | U | U | U | L | L | U | | LBY (2019) [140] | U | U | U | U | L | L | U | | LSQ (2017) [141] | L | U | U | U | L | L | U | | YL (2018) [142] | U | U | U | U | L | L | U | | ZQ (2016) [143] | U | U | U | U | L | L | U | | ZCY (2018) [144] | U | U | U | U | L | L | U | | ZGB (2017) [145] | U | U | U | U | L | L | U | | GLJNT (2017) [146] | U | U | U | U | L | L | U | | CJH (2016) [147] | U | U | U | U | L | L | U | | AYGL (2018) [148] | L | U | U | U | L | L | U | | SXX (2018) [149] | U | U | U | U | L | L | U | | XCY (2015) [150] | L | U | U | U | L | L | U | | HF (2016) [151] | L | U | U | U | L | L | U |
|
|
L, low risk; U, unclear risk; H, high risk.
|
